Omega-3’s mixed impact on blood sugar sparks debate in diabetes care

Omega-3 fatty acids, commonly found in fish oil supplements, have long been studied for their possible effects on blood sugar control. However, a 2024 review of 30 clinical trials has found mixed results, leaving experts divided on their real benefits for people managing type 2 diabetes.

Researchers analysed data from 30 randomised controlled trials to assess whether omega-3 supplements could help regulate blood sugar. Some participants showed lower fasting glucose levels after taking the supplements, while others experienced no noticeable change. The inconsistency in findings has made it difficult to draw firm conclusions.

The American Diabetes Association currently does not recommend omega-3 supplements as a standard treatment for diabetes. Official guidelines highlight a lack of strong evidence proving their effectiveness in improving blood sugar control. Despite this, omega-3s may still be suggested for individuals with type 2 diabetes who also face a higher risk of heart disease, as the fatty acids are linked to cardiovascular benefits. Experts also warn that anyone considering omega-3 supplements should first consult a doctor. Potential interactions with other medications could pose risks, making professional advice essential before starting any new supplement regimen.

The debate over omega-3’s role in blood sugar management continues, with studies producing conflicting outcomes. While not universally recommended for diabetes care, these supplements may still offer heart-related advantages for certain patients. For now, medical guidance remains key before incorporating them into a health plan.